Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13D/A for Lyra Therapeutics, Inc. Common Stock, $0.001 par value (LYRA).
- Disclosed ownership: 16%.
- Date of event: 12 Aug 2025.
PERCEPTIVE ADVISORS LLC - 12 Aug 2025 SCHEDULE 13D/A Report for Lyra Therapeutics, Inc. Common Stock, $0.001 par value (LYRA)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- LYRA
- Shares outstanding
- 1,644,695 shares
- Disclosed Ownership
- 255,750 shares
- Ownership
- 16%
- Form type
- SCHEDULE 13D/A
- Filing time
- 14 Aug 2025, 17:21:55 UTC
- Date of event
- 12 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 16% ownership in Lyra Therapeutics, Inc. Common Stock, $0.001 par value (LYRA) on 12 Aug 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 17:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 16% | 255,750 | 0 | 255,750 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | 0001224962 |
| Joseph Edelman | 16% | 255,750 | 0 | 255,750 | /s/ Joseph Edelman | Joseph Edelman | 0001164426 |
| Perceptive Life Sciences Master Fund, Ltd. | 14% | 229,982 | 0 | 229,982 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | 0001249675 |
| Perceptive LS (A), LLC | 1.6% | 25,768 | 0 | 25,768 | Perceptive LS GP, LLC | Joseph Edelman, Member | 0001797811 |